CareSignal Announces Partnership with Innovaccer

August 6, 2020 / Nueterra Capital Marketing

Nueterra Capital portfolio company CareSignal has announced a partnership with Innovaccer to combine more than two dozen condition-specific patient monitoring programs with population health data insights for more integrated care and improved clinical outcomes. CareSignal provides patient engagement and monitoring tools to identify patients whose health is worsening in the community and offers evidence-based, end-to-end support services for chronic medical conditions such as asthma, CHF, COPD, diabetes, depression, and hypertension. Healthcare technology company Innovaccer leverages artificial intelligence and analytics to automate routine workflows and reduce manual overhead to facilitate more person-centered care. You can read more here.